Literature DB >> 33976099

Fluvoxamine for COVID-19?

.   

Abstract

Entities:  

Keywords:  COVID-19; Luvox; SSRIs; Veklury; adverse effects; dosage; efficacy; fluvoxamine; remdesivir; safety

Mesh：

Substances：

Year:  2021        PMID： 33976099

Source DB:  PubMed          Journal:  Med Lett Drugs Ther        ISSN： 0025-732X            Impact factor:   1.909


× No keyword cloud information.
  1 in total

Review 1.  Fluvoxamine for the treatment of COVID-19.

Authors:  John Lz Nyirenda; Mario Sofroniou; Ingrid Toews; Agata Mikolajewska; Cornelius Lehane; Ina Monsef; Aesha Abu-Taha; Andy Maun; Miriam Stegemann; Christine Schmucker
Journal:  Cochrane Database Syst Rev       Date:  2022-09-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.